| | Case/date of repeat revascularization | Age/gender | Evidence of CVI | Diagnosis | Heart rate | RR | SpO2 | Date of prior revascularization | CAG: damage | EF | ECG | Comorbidities |
| | Persons with restenosis who underwent CVI (studied group) | | 1/23.06.2021 | 65/male | May 2021 pneumonia | STEMI | 76 | 18 | 97 | 2016, (5 years) | RCA, LAD | 25% | Sinus rhythm, (-+) tooth T I, AVL, (−) T V5V6 | AH, DM | | 18.01.2021 (5 months) | | 2/12.05.2021 | 69/male | September 2020 | NSTEMI | 92 | 22 | 95 | 2014 (7 years) | RCA | 35 | Sinus rhythm | AH | | 3/22.08.2021 | 66/female | May 2021 | STEMI | 100 | 26 | 87 | 2013 (8 years) | LAD | 55% | Sinus rhythm. ST-elevation V1–V5 | AH, DM | | 4/03.12.2021 | 80/male | Current pneumonia | STEMI | 108 | 32 | 78 | 2017 (4 years) | LAD | 26% | Sinus rhythm. ST segment elevation in I, aVL, V3–V6 | AH, CVA, Paroxysmal AF | | 5/09.11.2021 | 66/male | July 2021 | STEMI | 102 | 24 | 92 | 2012 (9 years) | LCx | 34% | Sinus rhythm. QS V1–V3. | AH, DM, CKD | | 6/10.11.2021 | 59/male | August 2021 | STEMI | 96 | 23 | 95 | 2021 (8 days) | LAD | 41% | Sinus rhythm. MI of the septal, anterior, lateral wall | AH | | 7/12.11.2021 | 71/female | December 2020 pneumonia | STEMI | 98 | 23 | 95 | 2020 (11 months) | LAD and LCx | 44% | Sinus rhythm. Complete left bundle branch block | AH, CVA, BA, CKD | | 8/08.11.2021 | 46/male | August 2021 pneumonia | NSTEMI | 67 | 18 | 97 | 2016 (5 years) | LAD | 52% | Sinus rhythm | AH | | 9/07.11.2021 | 70/female | October 2021 | STEMI | 70 | 18 | 98 | 2007 (14 years) | LCx | 56% | Sinus rhythm AV block 1st degree | AH, CVA, Hypothyroidism | | 10/07.12.2021 | 65/male | July 2021 | NSTEMI | 70 | 20 | 97 | 2008 (13 years) | LCx, RCA | 48% | Sinus rhythm | AH, DM |
| | Persons with restenosis without CVI (comparison group) | | 11/04.11.2021 | 72/male | No | STEMI | 80 | 18 | 97 | 2010 (11 years) | RCA | 35% | Sinus rhythm | AH | | 12/05.11.21 | 64/female | No | NSTEMI | 60 | 18 | 98 | 2019 (2 years) | RCA | 52% | Sinus rhythm, transitory left bundle branch block | AH, DM | | 13/23.07.2021 | 63/male | No | STEMI | 70 | 20 | 97 | 2019 (2 years) | RCA | 41% | Sinus rhythm | AH, DM | | 14/05.11.2021 | 70/male | No | NSTEMI | 80 | 19 | 98 | September 2021 (2 months) | LAD | 61% | Sinus rhythm | AH | | 15/07.05.2021 | 67/male | No | STEMI | 148 | 24 | 95 | 2020 г (1 year) | LCx | 35% | Atrial fibrillation | AH | | 16/09.10.2021 | 49/male | No | STEMI | 78 | 21 | 95 | 2012 г (9 years) | LAD | 56% | Sinus rhythm | AH | | 17/02.06.2021 | 65/male | No | STEMI | 100 | 22 | 96 | 2020 г (1 year) | LAD | 24% | Atrial fibrillation | AH, DM | | 18/11.05.2021 | 82/female | No | STEMI | 64 | 20 | 96 | March 2021 (2 months) | LAD | 56% | Sinus rhythm | AH | | 19/15.06.2021 | 72/male | No | STEMI | 70 | 21 | 95 | May 2021 (1 month) | RCA | 32% | Atrial fibrillation | AH | | 20/09.06.2021 | 57/male | No | NSTEMI | 92 | 21 | 97 | 2017 (4 years) | LAD | 50% | Sinus rhythm | AH |
|
|
